Charles Hoiberg

598 total citations
6 papers, 427 citations indexed

About

Charles Hoiberg is a scholar working on Pharmaceutical Science, Economics and Econometrics and Mechanical Engineering. According to data from OpenAlex, Charles Hoiberg has authored 6 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmaceutical Science, 2 papers in Economics and Econometrics and 2 papers in Mechanical Engineering. Recurrent topics in Charles Hoiberg's work include Pharmaceutical Economics and Policy (2 papers), Crystallization and Solubility Studies (2 papers) and Drug Solubulity and Delivery Systems (2 papers). Charles Hoiberg is often cited by papers focused on Pharmaceutical Economics and Policy (2 papers), Crystallization and Solubility Studies (2 papers) and Drug Solubulity and Delivery Systems (2 papers). Charles Hoiberg collaborates with scholars based in United States and Germany. Charles Hoiberg's co-authors include Ralph R. Pfeiffer, Guirag Poochikian, Stephen R. Byrn, Ravindra W. Tejwani, Samir Patel, William E. Brown, Fernando J. Muzzio, Thomas García, Rao S. Rapaka and Roger Williams and has published in prestigious journals such as Pharmaceutical Research, Journal of Pharmaceutical Innovation and PubMed.

In The Last Decade

Charles Hoiberg

6 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Hoiberg United States	5	253	139	136	105	56	6	427
Francis X. Muller United States	11	254 1.0×	196 1.4×	95 0.7×	108 1.0×	57 1.0×	15	462
Agam R. Sheth United States	10	325 1.3×	162 1.2×	120 0.9×	156 1.5×	56 1.0×	15	517
Guirag Poochikian United States	9	264 1.0×	148 1.1×	201 1.5×	107 1.0×	96 1.7×	13	598
Anthony Maher Ireland	9	351 1.4×	62 0.4×	111 0.8×	144 1.4×	45 0.8×	13	431
Vishal Koradia Denmark	11	345 1.4×	320 2.3×	163 1.2×	158 1.5×	101 1.8×	15	652
Janan Jona United States	14	244 1.0×	271 1.9×	157 1.2×	69 0.7×	70 1.3×	21	625
Yasuo Ida Japan	12	263 1.0×	312 2.2×	141 1.0×	83 0.8×	57 1.0×	21	590
Madhu Pudipeddi United States	7	312 1.2×	248 1.8×	152 1.1×	143 1.4×	56 1.0×	8	568
Ron C. Kelly United States	10	396 1.6×	279 2.0×	162 1.2×	181 1.7×	52 0.9×	14	650
J. C. Guyot France	12	292 1.2×	351 2.5×	69 0.5×	144 1.4×	95 1.7×	18	562

Countries citing papers authored by Charles Hoiberg

Since Specialization

Citations

This map shows the geographic impact of Charles Hoiberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Hoiberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Hoiberg more than expected).

Fields of papers citing papers by Charles Hoiberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Hoiberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Hoiberg. The network helps show where Charles Hoiberg may publish in the future.

Co-authorship network of co-authors of Charles Hoiberg

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Hoiberg. A scholar is included among the top collaborators of Charles Hoiberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Hoiberg. Charles Hoiberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Tejwani, Ravindra W., et al.. (2014). Assessment of Blend and Content Uniformity. Technical Discussion of Sampling Plans and Application of ASTM E2709/E2810. Journal of Pharmaceutical Innovation. 10(1). 84–97. 15 indexed citations

2.

García, Thomas, Ravindra W. Tejwani, William E. Brown, et al.. (2014). Recommendations for the Assessment of Blend and Content Uniformity: Modifications to Withdrawn FDA Draft Stratified Sampling Guidance. Journal of Pharmaceutical Innovation. 10(1). 76–83. 31 indexed citations

3.

Layloff, Thomas, Moheb Nasr, R. W. Baldwin, et al.. (2000). The FDA regulatory methods validation program for new and abbreviated new drug applications. 24(1). 30–42. 4 indexed citations

4.

Byrn, Stephen R., et al.. (1995). Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations. Pharmaceutical Research. 12(7). 945–954. 370 indexed citations

5.

Hoiberg, Charles & Rao S. Rapaka. (1991). FDA Regulatory Requirements for Investigational New Drugs and New Drug Applications: An Update. PsycEXTRA Dataset. 112. 313–25. 1 indexed citations

6.

Hoiberg, Charles. (1989). Aluminum in parenteral products: overview of chemistry concerns and regulatory actions.. PubMed. 43(3). 127–31. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact